000919 金陵药业
已收盘 04-27 15:00:00
资讯
新帖
简况
图解金陵药业一季报:第一季度单季净利润同比增长21.85%
证券之星 · 04:33
图解金陵药业一季报:第一季度单季净利润同比增长21.85%
金陵药业“三连击”背后:内生受阻、外延存疑,老牌药企陷入多重困局
新浪证券 · 04-24
金陵药业“三连击”背后:内生受阻、外延存疑,老牌药企陷入多重困局
金陵药业:截至2026年4月20日,公司股东人数为59,050
证券之星 · 04-22
金陵药业:截至2026年4月20日,公司股东人数为59,050
黄果任国家药监局党组书记;全国四成统筹地区已完成上年度清算
21世纪经济报道 · 04-17
黄果任国家药监局党组书记;全国四成统筹地区已完成上年度清算
金陵药业最新公告:控股子公司被法院移送破产审查
证券之星 · 04-16
金陵药业最新公告:控股子公司被法院移送破产审查
金陵药业(000919.SZ)分公司收到药品上市申请不予批准通知
智通财经 · 04-15
金陵药业(000919.SZ)分公司收到药品上市申请不予批准通知
A股收评 | 沪指微涨0.01% 伊朗局势突发!全球午后突变
智通财经网 · 04-15
A股收评 | 沪指微涨0.01% 伊朗局势突发!全球午后突变
国办一纸文件定调药价,创新药爆发!涨停名单还在拉长
格隆汇 · 04-15
国办一纸文件定调药价,创新药爆发!涨停名单还在拉长
金陵药业最新公告:拟收购四药公司100%股权
证券之星 · 04-13
金陵药业最新公告:拟收购四药公司100%股权
4月13日金陵药业(000919)龙虎榜数据:机构净卖出5051.65万元
证券之星 · 04-13
4月13日金陵药业(000919)龙虎榜数据:机构净卖出5051.65万元
4月9日金陵药业(000919)龙虎榜数据:机构净卖出854.63万元
证券之星 · 04-09
4月9日金陵药业(000919)龙虎榜数据:机构净卖出854.63万元
异动快报:金陵药业(000919)4月8日9点42分触及涨停板
证券之星 · 04-08
异动快报:金陵药业(000919)4月8日9点42分触及涨停板
金陵药业:截至2026年3月31日,公司股东人数为33,297
证券之星 · 04-02
金陵药业:截至2026年3月31日,公司股东人数为33,297
图解金陵药业年报:第四季度单季净利润同比增长59.99%
证券之星 · 03-31
图解金陵药业年报:第四季度单季净利润同比增长59.99%
股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元
证券之星 · 03-24
股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元
金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%
证券之星 · 03-12
金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%
金陵药业:截至2026年2月27日,公司股东人数为34,125
证券之星 · 03-03
金陵药业:截至2026年2月27日,公司股东人数为34,125
股市必读:金陵药业(000919)2月25日董秘有最新回复
证券之星 · 02-26
股市必读:金陵药业(000919)2月25日董秘有最新回复
金陵石化与京东政企业务签署合作协议
中国石化报 · 02-25
金陵石化与京东政企业务签署合作协议
金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%
证券之星 · 02-24
金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%
加载更多
公司概况
公司名称:
金陵药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-11-18
主营业务:
金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。
发行价格:
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":7.28,"timestamp":1777273395000,"preClose":7.36,"halted":0,"volume":25572500,"delay":0,"changeRate":-0.0109,"floatShares":622000000,"shares":622000000,"eps":0.1085,"marketStatus":"已收盘","change":-0.08,"latestTime":"04-27 15:00:00","open":7.29,"high":7.31,"low":7.17,"amount":185000000,"amplitude":0.019,"askPrice":7.28,"askSize":1342,"bidPrice":7.27,"bidSize":2576,"shortable":0,"etf":0,"ttmEps":0.1085,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.36,"symbolType":"stock","openAndCloseTimeList":[[1777253400000,1777260600000],[1777266000000,1777273200000]],"highLimit":8.1,"lowLimit":6.62,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.21,"roa":"--","peRate":67.096774,"roe":"1.42%","epsLYR":0.0867,"committee":-0.068966,"marketValue":4528000000,"turnoverRate":0.0411,"status":1,"floatMarketCap":4526000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2630310621","title":"图解金陵药业一季报:第一季度单季净利润同比增长21.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310621","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630310621?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:33","pubTimestamp":1777322034,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业2026年一季报显示,一季度公司主营收入7.69亿元,同比下降5.1%;归母净利润2800.31万元,同比上升21.85%;扣非净利润1926.2万元,同比下降5.76%;负债率19.36%,投资收益382.04万元,财务费用-99.56万元,毛利率21.51%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800012375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815149","title":"金陵药业“三连击”背后:内生受阻、外延存疑,老牌药企陷入多重困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815149","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815149?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:03","pubTimestamp":1777017780,"startTime":"0","endTime":"0","summary":"短短一周内,金陵药业接连发布三则重磅公告:拟收购常州四药、核心仿制药上市被否、控股子公司被移送破产审查。一桩桩事件接连抛出,表面看是偶然的公告密集期,实则折射出这家老牌药企正在经历的深层困境。 一边是内生发展频频受挫,一边是外延扩张仓促自救。金陵药业,正站在十字路口。 4月15日,金陵药业公告,其新产品碳酸司维拉姆干混悬剂因“现有资料不能支持该药品体外生物等效性结论”,被国家药监局拒之门外。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-24/doc-inhvqwcw4357482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629195018","title":"金陵药业:截至2026年4月20日,公司股东人数为59,050","url":"https://stock-news.laohu8.com/highlight/detail?id=2629195018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629195018?lang=zh_cn&edition=full","pubTime":"2026-04-22 15:45","pubTimestamp":1776843922,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)04月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截止到2026年4月20日公司股东人数是多少?谢谢!金陵药业回复:投资者,您好!截至2026年4月20日,公司股东人数为59,050,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200032218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","000919","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628228518","title":"黄果任国家药监局党组书记;全国四成统筹地区已完成上年度清算","url":"https://stock-news.laohu8.com/highlight/detail?id=2628228518","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628228518?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:10","pubTimestamp":1776384629,"startTime":"0","endTime":"0","summary":"政策动向全国四成统筹地区已提速完成上年度清算4月16日,国家医保局发布消息,截至2026年3月31日,全国30个省份(含新疆生产建设兵团)共154个统筹地区完成上年度清算,覆盖率达全国统筹区总数的39%,超额完成试点任务。其中,吉林白山、浙江宁波等43个非试点地区主动对标试点标准同步完成清算任务。山东、宁夏、北京、河北、海南、天津、河南等7个省(区、市)完成全省(区、市)清算。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604173708185460.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604173708185460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0820561909.HKD","688271","IE0004445239.USD","IE0004445015.USD","SG9999014898.SGD","LU0471298777.SGD","LU1988902786.USD","LU0316494557.USD","LU2756315664.SGD","SG9999014880.SGD","LU2271345857.HKD","LU0133085943.USD","LU0353189680.USD","LU2111349929.HKD","LU0683600562.USD","SG9999017495.SGD","IE00B1BXHZ80.USD","LU2324357040.USD","BK4516","SG9999001176.SGD","LU0158827781.USD","LU2023250504.SGD","LU1291159041.SGD","LU0708995401.HKD","SGXZ81514606.USD","300871","LU2237443978.SGD","LU2471134952.CNY","LU2237443895.HKD","SG9999015978.USD","LU0203201768.USD","LU1057294990.SGD","LU2168564149.EUR","LU2089984988.USD","LU2357305700.SGD","LU1629891620.HKD","LU2461242641.AUD","GB00BDT5M118.USD","LU2462157665.USD","LU2552382132.HKD","LU0061475181.USD","LU0640476718.USD","SG9999014914.USD","LU1223082519.USD","LU0320765992.SGD","LU0432979614.USD","ELIL","LU0689472784.USD","LU1069344957.HKD","LU0354030438.USD","LU0672654240.SGD","LU1712237335.SGD","LU1868837136.USD","LU2023250330.USD","LU2089283258.USD","IE00BN29S564.USD","LU0353189763.USD","LU0238689110.USD","LU0456855351.SGD","LU0786609619.USD","LU1868836591.USD","SGXZ57979304.SGD","BK4599","LLII","LU1280957306.USD","LU2602419157.SGD","BK4007","LU2112291526.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0882574139.USD","LU0109391861.USD","LLY","LU1551013425.SGD","LU2264538146.SGD","LU2168563687.JPY","LU0820562030.AUD","LU1720051108.HKD","IE0002141913.USD","BK4585","LU1720051017.SGD","LU0097036916.USD","LU1989771016.USD","LU2265009873.SGD","SGXZ31699556.SGD","IE00B7KXQ091.USD","LU0964807845.USD","LU2746668974.SGD","IE00BJT1NW94.SGD","LU1093756325.SGD","SG9999015986.USD","LU0122379950.USD","LU2471134879.HKD","IE00BJJMRY28.SGD","SGXZ99366536.SGD","LU1868836914.USD","IE00BJLML261.HKD","LU0109394709.USD","IE00BKPKM429.USD","LU2237443465.HKD","BK0028","IE00B775H168.HKD","ELIS","IE00BK4W5L77.USD","LU2108987350.USD","LU2236285917.USD","LU0203202063.USD","LU0079474960.USD","LU0289739699.SGD","IE00BJJMRX11.SGD","LU2361044949.HKD","LU0882574055.USD","LU1804176565.USD","LU1093756168.USD","LU2456880835.USD","LU0320765059.SGD","LU2471134796.USD","LU2106854487.HKD","LU0323591593.USD","LLYX","LU1917777945.USD","IE0001KFT4U8.USD","IE00BWXC8680.SGD","LU1267930730.SGD","LU2360106947.USD","LU0354030511.USD","IE00BKDWB100.SGD","LU2750360641.GBP","LU0820561818.USD","LU0106261372.USD","LU2063271972.USD","LU2089284900.SGD","LU0225283273.USD","BK4082","IE00B4JS1V06.HKD","LU0471298694.HKD","IE00B2B36J28.USD","LU0417517546.SGD","LU0114720955.EUR","LU0094547139.USD","BK0096","IE00BFTCPJ56.SGD","LU0256863902.USD","IE0009355771.USD","BK4168","LU1868837300.USD","LU0096364046.USD","SG9999018865.SGD","LU2746668461.USD","PYNKF","LU2028103732.USD","LU2552382058.USD","LU0943347566.SGD","LU2087625088.SGD","LU2237438978.USD","SG9999014906.USD","LU0823434583.USD","IE0005OL40V9.USD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1366192091.USD","LU0158827948.USD","LU2237443622.USD","LU0198837287.USD","LU2168564065.EUR","LU1127390331.HKD","LU0256863811.USD","LU2552382215.SGD","BK4533","SG9999015952.SGD","LU2168564495.EUR","LU2756315318.SGD","LU2211815571.USD","LU1974910355.USD","LU0823434740.USD","LU2213496289.HKD","LU1061106388.HKD","LU2491050154.USD","BK4588","LU1983299246.USD","IE00B4R5TH58.HKD","LU1623119135.USD","LU0234572021.USD","LU0787776722.HKD","BK4017","BK4534","LU0058720904.USD","LU1323610961.USD","LU1868836757.USD","LU2468319806.SGD","LU1023059063.AUD","LU2237443549.SGD","LU2237443382.USD","SG9999001176.USD","000919","LU2750360997.AUD","LU0006306889.USD","LU0889565916.HKD","LU2491049909.HKD","LU2471134523.USD","LU1145028129.USD","LU1814569148.SGD","IE00BFSS7M15.SGD","BK4581","LU1223082196.USD","LLYZ","LU2417539215.USD","LU2491050071.SGD","LU0266013472.USD","SG9999015945.SGD","LU1551013342.USD","LU2168564222.USD","LU0385154629.USD","LU1064131342.USD","SG9999018857.SGD","LU1035775433.USD","LU1548497426.USD","LU1223083913.SGD","BK0239","LU0210536198.USD","LU1232071149.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","IE00B1XK9C88.USD","LU2896262040.SGD","LU2361045086.USD","SG9999013999.USD","IE00BFSS8Q28.SGD","LU2023251221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627994222","title":"金陵药业最新公告:控股子公司被法院移送破产审查","url":"https://stock-news.laohu8.com/highlight/detail?id=2627994222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627994222?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:59","pubTimestamp":1776333593,"startTime":"0","endTime":"0","summary":"金陵药业公告称,公司近日收到控股子公司南京金鼓医院管理有限公司转来的法院文书,其作为被执行人的执行案件已移送南京市玄武区人民法院进行破产审查,法院已依法登记立案。鉴于金鼓公司已全面停止经营,且公司此前已审议通过解散清算该子公司的议案,公司不存在为其提供担保或财务资助情形。金鼓公司将从法院裁定破产、管理人接管日起,不再纳入公司财务报表合并范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600034597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","000919","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627401642","title":"金陵药业(000919.SZ)分公司收到药品上市申请不予批准通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2627401642","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627401642?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:48","pubTimestamp":1776239320,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金陵药业(000919.SZ)公告,公司分公司金陵药业股份有限公司南京金陵制药厂(简称“金陵制药厂”)于近日收到国家药品监督管理局下发的《药品上市申请不予批准通知书》,相关药品名称为:碳酸司维拉姆干混悬剂。该药品主要用于控制正在接受透析治疗的慢性肾脏病(CKD)成人患者的高磷血症等的治疗。本次不予批准的原因为:现有资料不能支持该药品体外生物等效性结论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","IPOS","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627062554","title":"A股收评 | 沪指微涨0.01% 伊朗局势突发!全球午后突变","url":"https://stock-news.laohu8.com/highlight/detail?id=2627062554","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627062554?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:08","pubTimestamp":1776236903,"startTime":"0","endTime":"0","summary":"截至收盘,沪指涨0.01%报4027.21点,成交10289亿元;深成指跌0.97%报14498.45点,成交13726亿元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260415/20260415150338_75294.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260415/20260415150338_75294.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["510300","159967","515890","000300.SH","002788","688166","600664","510880","399001","512510","000905.SH","002361","000688.SH","002808","000070","002926","002083","001208","301292","300502","512880","399006","688313","000001","600918","688353","600488","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627405121","title":"国办一纸文件定调药价,创新药爆发!涨停名单还在拉长","url":"https://stock-news.laohu8.com/highlight/detail?id=2627405121","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627405121?lang=zh_cn&edition=full","pubTime":"2026-04-15 14:33","pubTimestamp":1776234822,"startTime":"0","endTime":"0","summary":"政策组合拳出击","market":"sg","thumbnail":"https://img3.gelonghui.com/a401d-f3f18d25-b1d2-4d82-b91d-544aa33cb569.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-f3f18d25-b1d2-4d82-b91d-544aa33cb569.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4422353","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02162","BK0122","BK0197","BK0209","BK0102","002589","06990","BK0185","06978","BK1583","BK0070","BK0012","600488","BK1574","002038","BK1587","301408","BK0028","BK0077","BK0239","BK0250","600572","600267","BK0060","000919","BK0188","BK0096","LU0196878994.USD","000788","159992","BK0097","BK0132","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627434047","title":"金陵药业最新公告:拟收购四药公司100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2627434047","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627434047?lang=zh_cn&edition=full","pubTime":"2026-04-13 18:50","pubTimestamp":1776077428,"startTime":"0","endTime":"0","summary":"金陵药业公告称,公司于2026年4月13日向常州四药制药有限公司递交了《投资意向函》,表明公司和/或公司参与控制的主体有意向以现金方式收购四药公司现股东持有的四药公司100%的股权。标的股权收购完成后,公司将直接或间接持有四药公司不低于51%的股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300026564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627596436","title":"4月13日金陵药业(000919)龙虎榜数据:机构净卖出5051.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627596436","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627596436?lang=zh_cn&edition=full","pubTime":"2026-04-13 17:13","pubTimestamp":1776071592,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年4月13日公布的交易公开信息显示,金陵药业因日跌幅偏离值达到7%的前5只证券,连续三个交易日内,跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年4月13日收盘,金陵药业报收于7.25元,下跌8.58%,换手率15.86%,成交量98.58万手,成交额7.24亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出5051.65万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300022287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626009689","title":"4月9日金陵药业(000919)龙虎榜数据:机构净卖出854.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626009689","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626009689?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:12","pubTimestamp":1775725968,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年4月9日公布的交易公开信息显示,金陵药业因日振幅值达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月9日收盘,金陵药业报收于8.58元,下跌3.7%,换手率29.56%,成交量183.82万手,成交额17.22亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出854.63万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900027213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","000919","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625993480","title":"异动快报:金陵药业(000919)4月8日9点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2625993480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625993480?lang=zh_cn&edition=full","pubTime":"2026-04-08 09:45","pubTimestamp":1775612742,"startTime":"0","endTime":"0","summary":"证券之星4月8日盘中消息,9点42分金陵药业触及涨停板。其所属行业化学制药目前上涨。该股为创投,互联网医疗,民营医院概念热股,当日创投概念上涨2.75%,互联网医疗概念上涨2.54%,民营医院概念上涨2.44%。4月7日的资金流向数据方面,主力资金净流入9259.21万元,占总成交额30.34%,游资资金净流出3764.16万元,占总成交额12.34%,散户资金净流出5495.06万元,占总成交额18.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800007739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","000919","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624617524","title":"金陵药业:截至2026年3月31日,公司股东人数为33,297","url":"https://stock-news.laohu8.com/highlight/detail?id=2624617524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624617524?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:33","pubTimestamp":1775100797,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至3月31日公司的股东是多少?谢谢金陵药业回复:投资者,您好!截至2026年3月31日,公司股东人数为33,297,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200014925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","000919","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623323557","title":"图解金陵药业年报:第四季度单季净利润同比增长59.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623323557","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623323557?lang=zh_cn&edition=full","pubTime":"2026-03-31 02:06","pubTimestamp":1774894012,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业2025年年报显示,当年度公司主营收入31.97亿元,同比下降2.56%;归母净利润5391.46万元,同比上升33.42%;扣非净利润3500.49万元,同比下降28.45%;其中2025年第四季度,公司单季度主营收入8.17亿元,同比上升8.83%;单季度归母净利润-1454.37万元,同比上升59.99%;单季度扣非净利润-2163.93万元,同比下降761.05%;负债率19.72%,投资收益3019.59万元,财务费用-1206.16万元,毛利率20.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100004962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621408298","title":"股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621408298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621408298?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:47","pubTimestamp":1774298831,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,金陵药业报收于6.59元,下跌7.18%,换手率2.39%,成交量14.87万手,成交额1.0亿元。交易信息汇总3月23日金陵药业收盘报6.59元,跌7.18%,当日成交1487.25万元。根据收盘数据统计,该股已连续3日下跌。前10个交易日资金流向情况:主力资金累计净流出3440.41万元,股价累计下跌9.52%。资金流向3月23日主力资金净流入81.77万元;游资资金净流入1473.07万元;散户资金净流出1554.84万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618831187","title":"金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618831187","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618831187?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:11","pubTimestamp":1773306674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年3月10日公司股东户数为3.34万户,较2月27日减少695.0户,减幅为2.04%。在化学制药行业个股中,金陵药业股东户数低于行业平均水平,截至3月10日,化学制药行业平均股东户数为3.42万户。从股价来看,2026年2月27日至2026年3月10日,金陵药业区间跌幅为1.59%,在此期间股东户数减少695.0户,减幅为2.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200027804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616316036","title":"金陵药业:截至2026年2月27日,公司股东人数为34,125","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616316036?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:16","pubTimestamp":1772522185,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)03月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2月底 公司股东人数有多少?谢谢金陵药业回复:投资者,您好!截至2026年2月27日,公司股东人数为34,125,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300021085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614032225","title":"股市必读:金陵药业(000919)2月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614032225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614032225?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:29","pubTimestamp":1772040551,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,金陵药业报收于7.67元,上涨1.19%,换手率2.39%,成交量14.86万手,成交额1.15亿元。截至2026年2月13日,公司股东人数为34,034,感谢您对公司的关注。公司公告汇总金陵药业股份有限公司关于全资子公司清算注销完成的公告金陵药业股份有限公司于2025年11月26日召开董事会,审议通过清算注销全资子公司湖州邦健天峰药业有限公司的议案。邦健天峰将不再纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600000813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614727514","title":"金陵石化与京东政企业务签署合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2614727514","media":"中国石化报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614727514?lang=zh_cn&edition=full","pubTime":"2026-02-25 08:47","pubTimestamp":1771980431,"startTime":"0","endTime":"0","summary":"本报讯 近日,金陵石化与京东政企业务在北京签署合作协议。金陵石化在能源供应与化工产品领域具有显著优势。京东政企业务则凭借京东集团稳定、高效的供应链基础设施,为政企客户提供一站式、全链路、场景化的数智采购供应链综合解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225084717a71baf07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225084717a71baf07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0164880469.USD","LU0164865239.USD","LU0348735423.USD","LU0456846285.SGD","LU0672654166.SGD","LU0499858602.USD","LU0314109678.HKD","LU1044876610.USD","LU0228367735.SGD","LU0345776255.USD","LU0293314216.USD","LU0488056044.USD","BK1610","LU0499858438.USD","SG9999002828.SGD","LU0708995583.HKD","BK1588","IE00BGV7N243.SGD","LU1224444064.USD","LU1719994722.HKD","LU0456827905.SGD","LU2242644610.SGD","LU2257852520.SGD","LU1481107354.HKD","LU0048580855.USD","89618","IE00B3M56506.USD","09618","BK1619","JD","LU0348825331.USD","LU1282649810.SGD","LU0149721374.USD","LU0128522157.USD","LU0231483743.USD","LU0315179316.USD","LU1303224171.USD","IE00B29SXG58.USD","LU0359202008.SGD","BK1591","LU0588545904.SGD","LU1282651121.HKD","LU1770036033.HKD","LU0228659784.USD","LU1770034418.SGD","LU0791591158.USD","LU1808992512.USD","LU1044874839.SGD","LU0211977185.USD","LU0307460666.USD","LU0650527681.SGD","LU0370786039.SGD","LU0359201885.HKD","LU1282651048.USD","LU0384037296.USD","LU0039217434.USD","LU0588546209.SGD","LU0588545730.USD","LU0348805143.USD","LU0456842615.SGD","LU0140636845.USD","LU2039709279.SGD","LU0052750758.USD","LU0871576103.HKD","BK1249","LU1642822792.SGD","LU0315178854.USD","IE0032431581.USD","LU0417516738.SGD","LU0572944931.SGD","SG9999001226.SGD","LU1794554557.SGD","BK1615","000919","LU0588545490.SGD","LU0594300419.USD","LU0320764755.SGD","BK1142","LU1282649067.USD","LU1366334651.USD","LU0320764599.SGD","LU0163747925.USD","LU1366334578.USD","SG9999002562.SGD","LU1023057109.AUD","LU1720050803.USD","LU0469268626.HKD","LU0828237510.HKD","LU1251922891.USD","LU0359201612.USD","BK1502","LU0431992006.USD","LU0029875118.USD","LU0051755006.USD","LU0868486357.SGD","LU0084288322.USD","LU0327786744.USD","LU0531971595.HKD","LU0865486749.SGD","BK1575","LU0259732245.USD","LU0417516902.SGD","LU0345775950.USD","LU0791590937.USD","LU1328277881.USD","LU1044875133.USD","LU1813983027.USD","LU0543330483.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613790703","title":"金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613790703","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613790703?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:03","pubTimestamp":1771931037,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,金陵药业报收于7.58元,较前一交易日上涨1.88%,最新总市值为47.14亿元。金陵药业股份有限公司近日发布《关于全资子公司清算注销完成的公告》。公告显示,公司于2025年11月26日召开董事会,审议通过清算注销全资子公司湖州邦健天峰药业有限公司的议案。近日,公司收到湖州市市场监督管理局湖州南太湖区分局出具的《登记通知书》,邦健天峰清算注销手续已办理完毕。邦健天峰将不再纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777329726903,"stockEarnings":[{"period":"1week","weight":-0.0761},{"period":"1month","weight":0.0153},{"period":"3month","weight":-0.0667},{"period":"6month","weight":0.0196},{"period":"1year","weight":0.1259},{"period":"ytd","weight":-0.0843}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"59050人(较上一季度增加2.82%)","perCapita":"10529股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}